<DOC>
	<DOCNO>NCT00941161</DOCNO>
	<brief_summary>The aim study determinate effect combine oral therapy long act metformin/glimepiride single dose patient type 2 diabetes mellitus monotherapy failure .</brief_summary>
	<brief_title>Effect Oral Combination Therapy Single Dosage Form Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>A randomized double-blind clinical trial , determine effect combine therapy oral prolonged-release metformin/glimepiride single dosage form fast glucose HbA1c . Patients include study patient diabetes mellitus secondary failure monotherapy . Will also assess effect combine therapy oral lipid profile ( total cholesterol , LDL , HDL , VLDL , Triglycerides ) sensitivity insulin secretion . We evaluate clinical measurement , laboratory safety 3 month , allocation subject three study group ( metformin , glimepiride metformin extend release / glimepiride )</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>40 65 year old Ability communicate meet requirement study Signed Written Informed Consent conduct study Body Mass Index ( BMI ) = 2540kg/m2 Stable weight past three month ( variability &lt; 5 % ) Meal plan monotherapy oral hypoglycaemic fails Fasting glucose = 130270 mg/dL HbA1c &gt; 7 % isocaloric diet minimum 250 gram carbohydrate per day three day prior make laboratory test Suspected confirmed pregnancy Nursing Inability secure nonpregnant study duration Hypersensitivity drug study Treatment oral hypoglycemic insulin Consumption substance toxic effect organ system Liver failure , heart failure , kidney failure thyroid disease Chronic intake alcohol Periods acute chronic diarrhea vomit Consumption antifungal azoles , MAO inhibitor , nifedipine , furosemide , amiloride , digoxin , procainamide , quinidine , quinine , triamterene vancomycin</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>